Neurobiology of Aging
Volume 29, Issue 3 , Pages 319-328 , March 2008

Alzheimer's presenilin 1 causes chromosome missegregation and aneuploidy

  • Debrah I. Boeras

      Affiliations

    • Department of Molecular Medicine and Suncoast Gerontology Center, University of South Florida, College of Medicine, Tampa, FL 33612, USA
    • Johnnie B. Byrd Sr. Alzheimer's Center and Research Institute, Tampa, FL 33647, USA
    • Present address: Emory University, Emory Vaccine Center, 954 Gatewood Road, Atlanta, GA 30329, USA.
    • ,
  • Antoneta Granic

      Affiliations

    • Department of Molecular Medicine and Suncoast Gerontology Center, University of South Florida, College of Medicine, Tampa, FL 33612, USA
    • Johnnie B. Byrd Sr. Alzheimer's Center and Research Institute, Tampa, FL 33647, USA
    • ,
  • Jaya Padmanabhan

      Affiliations

    • Department of Molecular Medicine and Suncoast Gerontology Center, University of South Florida, College of Medicine, Tampa, FL 33612, USA
    • Johnnie B. Byrd Sr. Alzheimer's Center and Research Institute, Tampa, FL 33647, USA
    • ,
  • Nichole C. Crespo

      Affiliations

    • Johnnie B. Byrd Sr. Alzheimer's Center and Research Institute, Tampa, FL 33647, USA
    • ,
  • Amyn M. Rojiani

      Affiliations

    • Department of Pathology, University of South Florida College of Medicine, Tampa, FL 33612, USA
    • ,
  • Huntington Potter

      Affiliations

    • Department of Molecular Medicine and Suncoast Gerontology Center, University of South Florida, College of Medicine, Tampa, FL 33612, USA
    • Johnnie B. Byrd Sr. Alzheimer's Center and Research Institute, Tampa, FL 33647, USA
    • H.Lee Moffitt Cancer Center, Tampa, FL 33612, USA
    • Corresponding Author InformationCorresponding author at: Johnnie B. Byrd Sr. Alzheimer's Center and Research Institute, 15130 Amberly Drive, Tampa, FL 33647, USA. Tel.: +1 813 866 1600; fax: +1 813 866 1601.

Received 29 June 2006 ,Revised 27 September 2006 ,Accepted 25 October 2006.

References 

  1. Arendt T, Rodel L, Gartner U, Holzer M. Expression of the cyclin-dependent kinase inhibitor p16 in Alzheimer's disease. Neuroreport. 1996;7(18):3047–3049
  2. Chevallier NL, Soriano S, Kang DE, Masliah E, Hu G, Koo EH. Perturbed neurogenesis in the adult hippocampus associated with presenilin-1 A246E mutation. Am. J. Pathol. 2005;167(1):151–159
  3. Chui DH, Tanahashi H, Ozawa K, Ikeda S, Checler F, Ueda O, et al. Transgenic mice with Alzheimer presenilin 1 mutations show accelerated neurodegeneration without amyloid plaque formation. Nat. Med. 1999;5(5):560–564
  4. Duesberg P. Are centrosomes or aneuploidy the key to cancer?. Science. 1999;284(5423):2091–2092
  5. Duff K, Eckman C, Zehr C, Yu X, Prada CM, Perez-tur J, et al. Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1. Nature. 1996;383(6602):710–713
  6. Eckert A, Marques CA, Keil U, Schussel K, Muller WE. Increased apoptotic cell death in sporadic and genetic Alzheimer's disease. Ann. N.Y. Acad. Sci. 2003;1010:604–609
  7. Epstein CJ. The consequences of chromosome imbalance. Am. J. Med. Genet. Suppl. 1990;7:31–37
  8. Feng R, Wang H, Wang J, Shrom D, Zeng X, Tsien JZ. Forebrain degeneration and ventricle enlargement caused by double knockout of Alzheimer's presenilin-1 and presenilin-2. Proc. Natl. Acad. Sci. U.S.A. 2004;101(21):8162–8167
  9. Geller LN, Potter H. Chromosome missegregation and trisomy 21 mosaicism in Alzheimer's disease. Neurobiol. Dis. 1999;6(3):167–179
  10. Guo Q, Fu W, Sopher BL, Miller MW, Ware CB, Martin GM, et al. Increased vulnerability of hippocampal neurons to excitotoxic necrosis in presenilin-1 mutant knock-in mice. Nat. Med. 1999;5(1):101–106
  11. Haass C, De Strooper B. The presenilins in Alzheimer's disease—proteolysis holds the key. Science. 1999;286(5441):916–919
  12. Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science. 2002;297(5580):353–356
  13. Honda T, Nihonmatsu N, Yasutake K, Ohtake A, Sato K, Tanaka S, et al. Familial Alzheimer's disease-associated mutations block translocation of full-length presenilin 1 to the nuclear envelope. Neurosci. Res. 2000;37(2):101–111
  14. Husseman JW, Nochlin D, Vincent I. Mitotic activation: a convergent mechanism for a cohort of neurodegenerative diseases. Neurobiol. Aging. 2000;21(6):815–828
  15. Janicki SM, Monteiro MJ. Presenilin overexpression arrests cells in the G1 phase of the cell cycle arrest potentiated by the Alzheimer's disease PS2(N141I)mutant. Am. J. Pathol. 1999;155(1):135–144
  16. Janicki SM, Stabler SM, Monteiro MJ. Familial Alzheimer's disease presenilin-1 mutants potentiate cell cycle arrest. Neurobiol. Aging. 2000;21(6):829–836
  17. Johnsingh AA, Johnston JM, Merz G, Xu J, Kotula L, Jacobsen JS, et al. Altered binding of mutated presenilin with cytoskeleton-interacting proteins. FEBS Lett. 2000;465(1):53–58
  18. Kimura N, Nakamura SI, Honda T, Takashima A, Nakayama H, Ono F, et al. Age-related changes in the localization of presenilin-1 in cynomolgus monkey brain. Brain Res. 2001;922(1):30–41
  19. Kingsbury MA, Friedman B, McConnell MJ, Rehen SK, Yang AH, Kaushal D, et al. Aneuploid neurons are functionally active and integrated into brain circuitry. Proc. Natl. Acad. Sci. U.S.A. 2005;102(17):6143–6147
  20. Kulnane LS, Lehman EJ, Hock BJ, Tsuchiya KD, Lamb BT. Rapid and efficient detection of transgene homozygosity by FISH of mouse fibroblasts. Mamm. Genome. 2002;13(4):223–226
  21. Lemere CA, Lopera F, Kosik KS, Lendon CL, Ossa J, Saido TC, et al. The E280A presenilin 1 Alzheimer mutation produces increased A beta 42 deposition and severe cerebellar pathology. Nat. Med. 1996;2(10):1146–1150
  22. Li J, Xu M, Zhou H, Ma J, Potter H. Alzheimer presenilins in the nuclear membrane, interphase kinetochores, and centrosomes suggest a role in chromosome segregation. Cell. 1997;90(5):917–927
  23. Liesi P, Fried G, Stewart RR. Neurons and glial cells of the embryonic human brain and spinal cord express multiple and distinct isoforms of laminin. J. Neurosci. Res. 2001;64(2):144–167
  24. Lucarelli P, Piciullo A, Palmarino M, Verdecchia M, Saccucci P, Arpino C, et al. Association between presenilin-1-48C/T polymorphism and Down's syndrome. Neurosci. Lett. 2004;367(1):88–91
  25. Migliore L, Boni G, Bernardini R, Trippi F, Colognato R, Fontana I, et al. Susceptibility to chromosome malsegregation in lymphocytes of women who had a Down syndrome child in young age. Neurobiol. Aging. 2006;27(5):710–716
  26. Migliore L, Botto N, Scarpato R, Petrozzi L, Cipriani G, Bonuccelli U. Preferential occurrence of chromosome 21 malsegregation in peripheral blood lymphocytes of Alzheimer disease patients. Cytogenet. Cell Genet. 1999;87(1/2):41–46
  27. Murphy MP, Uljon SN, Fraser PE, Fauq A, Lookingbill HA, Findlay KA, et al. Presenilin 1 regulates pharmacologically distinct gamma-secretase activities. Implications for the role of presenilin in gamma-secretase cleavage. J. Biol. Chem. 2000;275(34):26277–26284
  28. Obrenovich ME, Raina AK, Ogawa O, Atwood CS, Morelli L, Smith MA. In: Nicoletti , Ferdinando , Agata Copani  editor. Alzheimer Disease—A New Beginning or a Final Exit?. Landes Bioscience: Eurekah.com; 2003;
  29. Petersen MB, Karadima G, Samaritaki M, Avramopoulos D, Vassilopoulos D, Mikkelsen M. Association between presenilin-1 polymorphism and maternal meiosis II errors in Down syndrome. Am. J. Med. Genet. 2000;93(5):366–372
  30. Potter H, Ma J, Das S, Geller LN, Benjamin M, Kayyali SS, et al. Beyond b-protein: new steps in the pathogenic pathway to Alzheimer's disease. In:  Iqbal K,  Mortimer JA,  Winblad B,  Wisniewski WH editor. In Research Advances in Alzheimer's Disease and Related Disorders. New York: John Wiley and Sons; 1995;p. 643–654
  31. Potter H. Cell cycle and chromosome segregation defects in Alzheimer's disease. In: Nicoletti , Ferdinando , Agata Copani  editor. Cell-cycle Mechanisms in Neuronal Death. Landes Bioscience: Eurekah.com; 2003;
  32. Potter H. Review and hypothesis: Alzheimer disease and Down syndrome–chromosome 21 non-disjunction may underlie both disorders. Am. J. Hum. Genet. 1991;48(6):1192–1200
  33. Potter H, Wefes IM, Nilsson LN. The inflammation-induced pathological chaperones ACT and apo-E are necessary catalysts of Alzheimer amyloid formation. Neurobiol. Aging. 2001;22(6):923–930
  34. Rehen SK, McConnell MJ, Kaushal D, Kingsbury MA, Yang AH, Chun J. Chromosomal variation in neurons of the developing and adult mammalian nervous system. Proc. Natl. Acad. Sci. U.S.A. 2001;98(23):13361–13366
  35. Rovelet-Lecrux A, Hannequin D, Raux G, Le Meur N, Laquerriere , Vital A, et al. APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy. Nat. Genet. 2006;38(1):11–12
  36. Saura CA, Choi SY, Beglopoulos V, Malkani S, Zhang D, Shankaranarayana Rao BS, et al. Loss of presenilin function causes impairments of memory and synaptic plasticity followed by age-dependent neurodegeneration. Neuron. 2004;42(1):23–36
  37. Schupf N, Kapell D, Lee JH, Ottman R, Mayeux R. Increased risk of Alzheimer's disease in mothers of adults with Down's syndrome. Lancet. 1994;344(8919):353–356
  38. Schupf N, Kapell D, Nightingale B, Lee JH, Mohlenhoff J, Bewley S, et al. Specificity of the five-fold increase in AD in mothers of adults with Down syndrome. Neurology. 2001;57(6):979–984
  39. Sleegers, K., Brouwers, N., Gijselinck, I., Theuns, J., Goossens, D., Wauters, J., Del-Favero, J., Cruts, M., van Duijn, C.M., Van Broeckhoven, C., 2006. APP duplication is sufficient to cause early onset Alzheimer's dementia with cerebral amyloid angiopathy. Brain, August 18 (Epub ahead of print).
  40. Tezapsidis N, Merz PA, Merz G, Hong H. Microtubular interactions of presenilin direct kinesis of Abeta peptide and its precursors. FASEB J. 2003;17(10):1322–1324
  41. Theuns J, Brouwers N, Engelborghs S, Sleegers K, Bogaerts V, Corsmit E, et al. Promoter mutations that increase amyloid precursor-protein expression are associated with Alzheimer disease. Am. J. Hum. Genet. 2006;78(6):936–946
  42. Vincent I, Rosado M, Davies P. Mitotic mechanisms in Alzheimer's disease?. J. Cell. Biol. 1996;132(3):413–425
  43. Vito P, Lacana E, D’Adamio L. Interfering with apoptosis: Ca(2+)-binding protein ALG-2 and Alzheimer's disease gene ALG-3. Science. 1996;271(5248):521–525
  44. Vito P, Wolozin B, Ganjei JK, Iwasaki K, Lacana E, D’Adamio L. Requirement of the familial Alzheimer's disease gene PS2 for apoptosis. Opposing effect of ALG-3. J. Biol. Chem. 1996;271(49):31025–31028
  45. Wang R, Dineley KT, Sweatt JD, Zheng H. Presenilin 1 familial Alzheimer's disease mutation leads to defective associative learning and impaired adult neurogenesis. Neuroscience. 2004;126(2):305–312
  46. Wen PH, Hof PR, Chen X, Gluck K, Austin G, Younkin SG, et al. The presenilin-1 familial Alzheimer disease mutant P117L impairs neurogenesis in the hippocampus of adult mice. Exp. Neurol. 2004;188(2):224–237
  47. Wolfe MS. The secretases of Alzheimer's disease. Curr. Top. Dev. Biol. 2003;54:233–261
  48. Wolozin B, Iwasaki K, Vito P, Ganjei JK, Lacana E, Sunderland T, et al. Participation of presenilin 2 in apoptosis: enhanced basal activity conferred by an Alzheimer mutation. Science. 1996;274(5293):1710–1713
  49. Yang Y, Geldmacher DS, Herrup K. DNA replication precedes neuronal cell death in Alzheimer's disease. J. Neurosci. 2001;21(8):2661–2668
  50. Yang Y, Mufson EJ, Herrup K. Neuronal cell death is preceded by cell cycle events at all stages of Alzheimer's disease. J. Neurosci. 2003;23(7):2557–2563
  51. Yuasa S, Nakajima M, Aizawa H, Sahara N, Koizumi K, Sakai T, et al. Impaired cell cycle control of neuronal precursor cells in the neocortical primordium of presenilin-1-deficient mice. J. Neurosci. Res. 2002;70(3):501–513

PII: S0197-4580(06)00398-8

doi: 10.1016/j.neurobiolaging.2006.10.027

Neurobiology of Aging
Volume 29, Issue 3 , Pages 319-328 , March 2008

Article Tools

* Image Usage & Resolution